Biotivia Bioforte Increased Cerebral Blood flow in New Human Clinical Trial

This is your brain on Bioforte

A brand new peer reviewed double blind human clinical trial was published this month which concluded that Biotivia's Bioforte in doses of both a single capsule and two capsules increased brain blood flow in 24 university students at Northumbria University in the UK.

This investigation is a hugely important addition to the body of human clinical data on the polyphenol and phytoalexin resveratrol.

The fact that Northumbria University chose Biotivia as the brand of supplement used in their trial is a strong endorsement of the quality and integrity of the company's products, particularly Biotivia's resveratrol-based supplements.

Biotivia is currently engaged in several other collaborations with major research institutions and expects more published human clinical studies to be published in scientific journals in the coming few months.

Download PDF

Download Word Document